Jan Møller Mikkelsen
Co-Founder, President and CEO @ Ascendis Pharma
Esbjerg, Denmark
Jan Møller Mikkelsen is a Series A investor at Ascendis Pharma in Esbjerg focused on Life Science and Biotechnology. Jan Møller Mikkelsen - Deputy Director @ Skattestyrelsen
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Jan Møller Mikkelsen invests in
Stages Jan Møller Mikkelsen invests in
Countries Jan Møller Mikkelsen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Life Science 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients in Greater China. | $150M / Series B / Jan 08, 2021 | ||
| Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients in Greater China. | $40M / Series A / Nov 13, 2018 |
Co-Investors
About Ascendis Pharma
Ascendis Pharma has built a high value pipeline with the aim of changing clinical treatment paradigms. Using our innovative TransCon prodrug technology platform, we continue to identify new opportunities addressing areas of high unmet medical need. TransCon is applicable to all drug classes, and is currently being used to create superior prodrugsof proteins, peptides and small molecules. Depending on choice of TransCon Carrier, either systemic or localized drug exposure is achieved, while dosing frequency is determined by the choice of TransCon Linker. The prodrugs are new chemical entities with new patent life. Product development process is de-risked, as the prodrugs release the active component in its native and unmodified form, maintaining the original drug’s well known mode of action.
Ascendis Pharma Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Birgitte Volck
Non Executive Director
|
|||
|
Harald Rau
Senior Vice President, Chief Scientific Officer
|
|||
|
Jan Møller Mikkelsen
Co-Founder, President and CEO
|
|||
Lotte Sønderbjerg
SVP Chief Administrative Offer Managing Director Ascendis GmbH
|
|||
|
Michael Beckert
Chief Medical Officer (acting)
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jan Møller Mikkelsen invest in?
Jan Møller Mikkelsen invests primarily in Life Science, Biotechnology and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jan Møller Mikkelsen?
Public channels for Jan Møller Mikkelsen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jan Møller Mikkelsen last invest?
The most recent investment recorded for Jan Møller Mikkelsen closed in Jan 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
